Wellbeing Day returns with a focus on community and self-care

Published on April 23, 2026
Organisers speak to OT about the importance of the event and the personal mental journey that led to its establishment
Continue reading on website
Other news

Wet AMD Patients Stand to Lose One Line of Vision from Lapse in Therapy, Study Says

April 22, 2026
With a significant number of neovascular age-related macular degeneration (nAMD) patients requiring repeated intravitreal injections and close monitoring to maintain vision, patient adherence to therapy regimens remains a significant challenge. In a retrospective multicenter study, researchers used data from the Fight Retinal Blindness! (FRB!) registry to evaluate visual outcomes and visit gap occ

Glaukos Receives Permanent J-code for Epioxa, a Treatment for Keratoconus

April 23, 2026
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, has announced the U.S. Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Epioxa HD/Epioxa for